1224
Can. J. Chem. Vol. 84, 2006
(s, 2H, NH), 11.70 (br, NH). 13C NMR (500 MHz, CD2Cl2)
δ: 12.95, 13.095, 13.18, 15.12, 16.33, 17.11, 17.21, 18.19,
21.44, 21.59, 32.26, 32.43, 34.59, 34.64, 117.92, 123.68,
126.87, 127.59, 128.09, 128.45, 134.20, 134.86, 136.08,
137.16, 139.27, 141.34, 144.15, 144.29, 148.18, 150.13,
158.59.
129.74, 131.69, 137.54, 138.09, 138.83, 139.80, 147.35,
148.89, 150.94.
2,7,20,25-Tetra-p-butylphenyl-11,16,29,34-tetramethyl-
12,15,30,33-tetracarboxylate-3,6,21,24-
tetraaza[32]octaphyrin(1.0.1.0.1.0.1.0) (3e)
The compound was obtained from the condensation of
biimidazole 1b (10) with bipyrrole 2c (17) in 26% yield, fol-
lowing the general procedure given above. UV–vis (CH3CN,
nm (ε)) λmax: 275 (34 300), 609 (4790). 1H NMR (400 MHz,
CD2Cl2) δ: 0.98 (m, 12H, CH2CH2CH2CH3), 1.44 (m,
8H, CH2CH2CH2CH3), 1.67 (m, 8H, CH2CH2CH2CH3),
2.05 (s, 12H, CH3), 2.45 (t, J = 7.4 Hz, 4H, CH2CH2), 2.62–
2.77 (comp, 12H, CH2CH2), 3.02 (t, J = 7.6 Hz,
CH2CH2CH2CH3), 3.21 (t, J = 7.2 Hz, 4H, CH2CH2CH2CH3),
3.30 (s, 6H, CO2CH3), 3.56 (s, 6H, CO2CH3), 7.00 (s, 2H,
meso-H), 7.13 (s, 2H, meso-H), 7.30 (d, J = 7.6 Hz, 4H),
7.41 (d, J = 8.0 Hz, 4H), 7.62 (d, J = 8 Hz, 4H), 7.82 (d, J =
8 Hz, 4H), 10.02 (s, 2H, NH).
2,7,20,25-Tetra-p-butylphenyl-11,16,29,34-tetraethyl-
12,15,30,33-tetramethyl-3,6,21,24-tetraaza[32]octaphyrin-
(1.0.1.0.1.0.1.0) (3b)
The compound was obtained from the condensation of
biimidazole 1b (10) with bipyrrole 2a (16)4 in 54% yield,
following the general procedure given above. UV–vis
(CH3CN, nm (ε)) λmax: 299 (139 000), 536 (68 500), 633
(142 000). 1H NMR (500 MHz, CD2Cl2) δ: 0.93–1.04
(comp, 18H, CH2CH3, CH2CH2CH2CH3), 1.16–1.21 (m, 6H,
CH2CH3), 1.36–1.47 (m, 8H, CH2CH2CH2CH3), 1.59–1.69
(comp, 8H, CH2CH2CH2CH3), 2.00 (s, 6H, CH3), 2.39–2.47
(comp, 14H, CH3 and CH2CH2CH2CH3), 2.61–2.72 (comp,
8H, CH2CH2CH2CH3), 6.87 (br, 2H, meso-H), 6.95 (s, 1H,
meso-H), 7.04 (br, 1H, meso-H), 7.19 (m, 2H), 7.25 (m, 2H),
7.46 (br, 4H), 7.49 (m, 2H), 7.59 (br, 2H), 7.72 (br, 4H),
9.87 (br, 2H). 13C NMR (500 MHz, CD2Cl2) δ: 10.95, 11.67,
14.11, 14.38, 15.64, 18.16, 18.69, 22.81, 33.98, 35.84,
119.71, 121.37, 126.50, 128.68, 129.10, 129.14, 129.42,
137.88, 143.97, 144.85, 147.48, 159.16.
Molecular modelling studies
Molecular modelling studies were performed using semi-
empirical calculations at the PM3 level, using HyperChem®
V7.1, for preoptimization. Density functional theory (DFT)
calculations were then performed using PRIRODA-04 (22).
A PBE functional that includes the electron density gradient
was used. The TZ2p atomic basis sets of grouped Gaussian
functions were used to solve the Kohn–Sham equations. The
criterion for convergence was to reach a difference in energy
gradient between two sequential structures below
0.01 kcal/mol/Å (1 cal = 4.184 J). A PDB file for each opti-
mized structure is included in the Supplementary informa-
tion.5
2,7,20,25-Tetra-p-methylphenyl-11,12,15,16,29,30,33,34-
octaethyl-3,6,21,24-tetraaza[32]octaphyrin(1.0.1.0.1.0.1.0)
(3c)
The compound was obtained from the condensation of
biimidazole 1a with bipyrrole 2b (16)4 in 62% yield, follow-
ing the general procedure given above. UV–vis (CH3CN, nm
(ε)) λmax: 299 (78 400), 540 (40 900), 634 (92 400). 1H
NMR (400 MHz, CD2Cl2) δ: 0.90–1.25 (comp, 24H,
CH2CH3), 2.36–2.99 (comp, 28H, CH3, CH2CH3), 6.89 (s,
1H, meso-H), 6.99 (s, 2H, meso-H), 7.06 (s, 1H, meso-H),
7.22–7.31 (comp, 4H), 7.39 (d, J = 7.6 Hz, 2H), 7.54 (m,
4H), 7.72 (d, J = 8.4 Hz, 2H), 7.84 (d, J = 7.6 Hz, 4H),
10.02 (s, 2H). 13C NMR (500 MHz, CD2Cl2) δ: 14.81,
15.22, 15.30, 16.86, 18.17, 18.61, 19.18, 19.54, 21.50,
127.81, 128.92, 129.73, 135.12, 138.73, 147.10, 148.25.
HR-MS (FAB+) m/z (M + H+) calcd. for C76H77N12:
1157.6394; found: 1157.6383.
Acknowledgements
This project was supported by the National Science Foun-
dation Integrative Graduate Education and Research
Traineeship Program (grant No. DGE 9870653) and the Na-
tional Science Foundation (grant No. CHE 0515670 to JLS).
We would also like to acknowledge Mr. Jeong Tae Lee for
providing bipyrrole 2c and Dr. Dmitri Laikov for providing
the DFT software PRIRODA-04.
References
2,7,20,25-Tetra-p-methylphenyl-11,16,29,34-tetraethyl-
12,15,30,33-tetramethyl-3,6,21,24-tetraaza[32]octaphyrin-
(1.0.1.0.1.0.1.0) (3d)
1. R.B. Woodward. In Aromaticity conference. Sheffield, UK.
1966.
2. J.L. Sessler and D. Seidel. Angew. Chem. Int. Ed. 42, 5134
(2003).
3. J.L. Sessler and S. Weghorn. Expanded, contracted, and iso-
meric porphyrins. Pergamon, New York. 1997.
4. J.L. Sessler and W.E. Allen. Chemtech, 9, 16 (1999).
5. J.L. Sessler, M. Cyr, H. Furuta, V. Kral, T. Mody, T.
Morishima, M. Shionoyam, and S. Weghorn. Pure Appl.
Chem. 3, 393 (1993).
The compound was obtained from the condensation of
biimidazole 1a with bipyrrole 2a (16)4 in 59% yield, follow-
ing the general procedure given above. UV–vis (CH3CN, nm
1
(ε)) λmax: 296 (253 000), 531 (140 000), 633 (326 000). H
NMR (500 MHz, CD2Cl2) δ: 1.02 (t, J = 7.5 Hz, 6H), 1.18
(m, 6H), 1.97 (s, 6H), 2.38–2.45 (comp, 6H, CH3, CH2CH3),
6.80 (s, 2H), 7.02 (s, 2H), 7.23 (m, 4H), 7.33 (br, 4H), 7.56
(m, 4H), 7.27 (br, 4H), 9.85 (br, 2H). 13C NMR (500 MHz,
CD2Cl2) δ: 10.87, 11.55, 14.18, 15.63, 18.17, 18.66, 21.44,
119.89, 121.28, 123.17, 124.99, 126.40, 128.69, 129.44,
6. H. Ali and J.E. Van Lier. Chem. Rev. 9, 2379 (1999).
7. J. Jasat and D. Dolphin. Chem. Rev. 6, 2267 (1997).
5 Supplementary data for this article are available on the journal Web site (http://canjchem.nrc.ca) or may be purchased from the Depository
of Unpublished Data, Document Delivery, CISTI, National Research Council Canada, Ottawa, ON K1A 0R6, Canada. DUD 5038. For more
© 2006 NRC Canada